|
| |
patent 6 274 554 Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
L - Index to the U.S. Patent Classification System
6 Membered ring .................... 549 / 274 7 Membered ring . ...... The Inventors Assistance Center is available to help you on patent matters. ...
http://www.uspto.gov/go/classification/uspcindex/indexl.htm...
|
Maastricht, Netherlands and War of First Coalition, 146 Mably ...
resolutions on TJ's Report on Commerce, 11, 21-2, 29, 34, 35-6, 38, 40-1, 44, 49 ... 38, 250-1, 274, 279, 542, 554; conveys news from Monroe, 45, 100, 316, ...
http://www.princeton.edu/~tjpapers/vol28/mo.html...
|
CONCORDANCE - United States to International Patent Classification
CONCORDANCE - United States to International Patent Classification ..... 554. ORGANIC COMPOUNDS --. PART OF THE CLASS. 532-570 SERIES. U.S. CLASS 554 ...
http://www.uspto.gov/go/classification/conpdf/us_con_554.pdf...
|
Ventricular septal defect and aortic regurgitation
1965 Nov;3(6):554–560. [PubMed]; CLAYPOOL JG, RUTH W, LIN TK. Ventricular septal defect with aortic incompetence simulating patent ductus arteriosus. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=47...
|
All Patent Types Report, 1977-2007 (includes utility, design ...
Patents By Year of Grant: 5103 615 554 706 610 776 671 592 726 697 646 520 464 .... ALL PATENT TYPES REPORT (U, D, PP, RE, T, SIR), 1977-2007. Page B - 6 ...
http://www.uspto.gov/go/taf/apat.pdf...
|
Nutritional status of children with congenital heart disease.
Factors in the growth of children with patent ductus arteriousus. Pediatrics. .... 1986 10(6):550–554.Nov–Dec; [PubMed]; Haydock DA, Hill GL. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=48...
|
2145 Consideration of Applicant's Rebuttal Arguments [R-6] - 2100 ...
The court in In re Hoeksema, 399 F.2d 269, 274, 158 USPQ 596, 601 (CCPA 1968), ... In the ex parte process of examining a patent application, however, ...
http://www.uspto.gov/web/offices/pac/mpep/documents/2100_214...
|
Patent and Exclusivity Terms
I-274, USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY ...... U -554, TREATING HIV INFECTION WITH INDINAVIR SULFATE IN COMBINATION WITH ...
http://www.fda.gov/cder/orange/patex.htm...
|
W - Index to the U.S. Patent Classification System
Information Products Division -- U.S. Patent and Trademark Office ... The Inventors Assistance Center is available to help you on patent matters. ...
http://www.uspto.gov/go/classification/uspcindex/indexw.htm...
|
Drug evaluation: Managlinat dialanetil, a fructose-1,6 ...
Patent summary. Managlinat dialanetil was first claimed generically within ..... PHYSIOL 1998 274 6 G1087-G1093. 311215 Metabasis Therapeutics achieves ...
http://www.biomedcentral.com/content/pdf/cd-834215.pdf...
|
|
